Juanita Romero-Diaz
Overview
Explore the profile of Juanita Romero-Diaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
3024
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nielsen W, Kharouf F, Grajales C, Thayaparan A, Anderson M, Strand V, et al.
Semin Arthritis Rheum
. 2025 Mar;
72:152684.
PMID: 40056477
Objective: To identify candidate Systemic Lupus Erythematosus (SLE) domains from the literature for consideration towards the development of the SLE Core Outcome Set. Methods: This was a comprehensive scoping literature...
2.
Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary
Werth V, Furie R, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven R, et al.
Immunotherapy
. 2025 Feb;
:1-13.
PMID: 39995069
No abstract available.
3.
Furie R, van Vollenhoven R, Kalunian K, Navarra S, Romero-Diaz J, Werth V, et al.
Immunotherapy
. 2025 Feb;
:1-13.
PMID: 39995062
No abstract available.
4.
Nielsen W, Strand V, Simon L, Pinsker E, Bonilla D, Morand E, et al.
Semin Arthritis Rheum
. 2024 Aug;
68:152520.
PMID: 39106780
Background: Since the development of the OMERACT Systemic Lupus Erythematosus (SLE) Core Outcome Set (COS) in 1998, many new SLE domains have been identified and measures developed, creating a need...
5.
Ocampo-Torres M, Hernandez-Molina G, Criales-Vera S, Sanchez-Guerrero J, Lara-Reyes P, Romero-Diaz J
J Rheumatol
. 2024 Jul;
51(10):991-996.
PMID: 38950947
Objective: To evaluate the progression of coronary artery calcification (CAC) and associated risk factors in a systemic lupus erythematosus (SLE) cohort. Methods: We reassessed the presence of CAC in patients...
6.
Barber M, Ugarte-Gil M, Hanly J, Urowitz M, St-Pierre Y, Gordon C, et al.
Ann Rheum Dis
. 2024 May;
83(10):1295-1303.
PMID: 38754981
Objectives: This study aims to determine the independent impact of definitions of remission/low disease activity (LDA) on direct/indirect costs (DCs, ICs) in a multicentre inception cohort. Methods: Patients from 31...
7.
Krustev E, Hanly J, Chin R, Buhler K, Urowitz M, Gordon C, et al.
Lupus Sci Med
. 2024 Apr;
11(1).
PMID: 38599670
Background: Cranial neuropathies (CN) are a rare neuropsychiatric SLE (NPSLE) manifestation. Previous studies reported that antibodies to the kinesin family member 20B (KIF20B) (anti-KIF20B) protein were associated with idiopathic ataxia...
8.
Nielsen W, Strand V, Simon L, Parodis I, Kim A, Desai M, et al.
Semin Arthritis Rheum
. 2024 Jan;
65:152380.
PMID: 38281467
Background: The Outcome Measures in Rheumatology (OMERACT) Systemic Lupus Erythematosus (SLE) Working Group held a Special Interest Group (SIG) at the OMERACT 2023 conference in Colorado Springs where SLE collaborators...
9.
Montufar-Robles I, Barbosa-Cobos R, Romero-Diaz J, Valencia-Pacheco G, Cabello-Gutierrez C, Ramirez-Bello J
Hum Immunol
. 2023 Dec;
85(1):110736.
PMID: 38042682
TNFAIP3 is a classical systemic lupus erythematosus (SLE)-associated risk locus identified by genome-wide association studies (GWASs) and replicated by candidate gene association studies primarily in Caucasians and Asians. However, in...
10.
Nguyen Y, Blanchet B, Urowitz M, Hanly J, Gordon C, Bae S, et al.
Arthritis Rheumatol
. 2023 Jul;
75(12):2195-2206.
PMID: 37459273
Objective: The goals of this study were to assess the associations of severe nonadherence to hydroxychloroquine (HCQ), objectively assessed by HCQ serum levels, and risks of systemic lupus erythematosus (SLE)...